Overview

Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury

Status:
Unknown status
Trial end date:
2021-03-30
Target enrollment:
Participant gender:
Summary
The current study aims to evaluate different doses of PC-SOD injections for efficacy and safety in comparison to placebo, in order to provide a basis for future clinical trials in terms of experimental design and dose selection.
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Tide Pharmaceutical Co., Ltd
Collaborator:
Peking University First Hospital
Treatments:
Superoxide Dismutase